133 related articles for article (PubMed ID: 2883645)
21. Characteristics of cyanopindolol analogues active at the beta 3-adrenoceptor in rat ileum.
Hoey AJ; Jackson CM; Pegg GG; Sillence MN
Br J Pharmacol; 1996 Oct; 119(3):564-8. PubMed ID: 8894179
[TBL] [Abstract][Full Text] [Related]
22. The sympathomimetic activity of (+/-)-pindolol at beta 1- and beta 2-adrenoceptor sites.
Mian MA; Malta E
Eur J Pharmacol; 1985 Feb; 109(1):65-71. PubMed ID: 2986991
[TBL] [Abstract][Full Text] [Related]
23. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
[TBL] [Abstract][Full Text] [Related]
24. Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies.
Molenaar P; Summers RJ
J Pharmacol Exp Ther; 1987 Jun; 241(3):1041-7. PubMed ID: 3037064
[TBL] [Abstract][Full Text] [Related]
25. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
Zaagsma J; Meems L; Boorsma M
Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
[No Abstract] [Full Text] [Related]
26. Affinity constants and beta-adrenoceptor reserves for isoprenaline on cardiac tissue from normotensive and hypertensive rats.
Doggrell SA; Petcu EB; Barnett CW
J Pharm Pharmacol; 1998 Feb; 50(2):215-23. PubMed ID: 9530991
[TBL] [Abstract][Full Text] [Related]
27. Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.
Kaumann AJ; Engelhardt S; Hein L; Molenaar P; Lohse M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):87-93. PubMed ID: 11191841
[TBL] [Abstract][Full Text] [Related]
28. Mode of action of (-)-pindolol on feline and human myocardium.
Kaumann AJ; Lobnig BM
Br J Pharmacol; 1986 Sep; 89(1):207-18. PubMed ID: 2879589
[TBL] [Abstract][Full Text] [Related]
29. (+/-)-Pindolol has beta 2-adrenoceptor antagonist but not agonist action on the costo-uterine muscle of the rat.
Pennefather JN; Hartley ML; Leedham JA
Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):581-5. PubMed ID: 2893676
[TBL] [Abstract][Full Text] [Related]
30. Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Sakuma N; Tsuchihashi H; Hosohata Y; Akashi H; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 May; 14(5):250-5. PubMed ID: 1685186
[TBL] [Abstract][Full Text] [Related]
31. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
32. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
[TBL] [Abstract][Full Text] [Related]
33. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
[TBL] [Abstract][Full Text] [Related]
34. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.
Barovsky K; Brooker G
J Cyclic Nucleotide Res; 1980; 6(4):297-307. PubMed ID: 6110683
[TBL] [Abstract][Full Text] [Related]
35. Pindolol increases plasma norepinephrine concentration by stimulation of beta 2-adrenoceptors in conscious spontaneously hypertensive rats.
Keeton TK
J Cardiovasc Pharmacol; 1990 Sep; 16(3):354-9. PubMed ID: 1700204
[TBL] [Abstract][Full Text] [Related]
36. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
37. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the beta 1-adrenoceptor stimulatory effects of the partial beta 1-agonists acebutolol, xamoterol, H142/08 and H201/70.
Abrahamsson T
Eur J Pharmacol; 1989 May; 164(1):121-8. PubMed ID: 2568935
[TBL] [Abstract][Full Text] [Related]
39. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
